Skip to main content
. 2022 Sep 5;22:385. doi: 10.1186/s12903-022-02420-x

Table 3.

Differences of six months of treatment outcome of TMDs accordance with the level of perceived role of decision-making

Baseline 6 months after treatment P value
Time Group Group*Time interaction
Amount of pain free opening (mm) Active-A 42.6 ± 8.1 47.6 ± 5.9 < 0.001** 0.185 0.692
Collaborate-A 42.4 ± 8.9 47.1 ± 5.8
Passive-A 42.0 ± 8.5 47.1 ± 6.5
Amount of maximum unassisted opening (mm) Active-A 45.3 ± 6.3 47.7 ± 6.0 0.006* 0.183 0.658
Collaborate-A 45.1 ± 7.3 47.3 ± 5.5
Passive-A 44.1 ± 6.7 47.6 ± 5.8
VAS for TMD Active-A 4.70 ± 2.61 1.17 ± 1.4 < 0.001** 0.311 < 0.001**
Collaborate-A 4.64 ± 1.98 2.62 ± 1.98
Passive-A 3.68 ± 2.68 4.00 ± 2.39
Number of active TrPs in masticatory muscles Active-A 0.75 ± 1.32 0.20 ± 0.69 < 0.001** 0.339 0.771
Collaborate-A 1.03 ± 1.83 0.43 ± 1.16
Passive-A 0.43 ± 0.97 0.04 ± 0.19
Number of latent TrPs in masticatory muscles Active-A 0.69 ± 1.08 0.44 ± 0.90 0.196 0.280 0.098
Collaborate-A 0.79 ± 0.97 0.14 ± 0.53
Passive-A 0.26 ± 0.62 0.26 ± 0.76
GCPS Active-A 3 (1–3) 1 (0–1) 0.006* 0.235
Collaborate-A 2 (1–3.25) 1 (0.5–2)
Passive-A 1 (1–3) 2 (1–3)

Descriptive values are shown as mean ± SD or median (25th – 75th percentile)

Data obtained from two-way repeated measure ANOVA

TMD Temporomandibular disorders; GCPS Graded chronic pain scale; TrP Trigger point; VAS Visual analog scale

Data obtained from Chi-square test

*P < 0.05, **P < 0.001 by two-way repeated measure ANOVA and Chi-square test